Understanding the impact of 1q21.1 copy number variant

[1]  Brian K. Kennedy,et al.  TOR on the brain , 2011, Experimental Gerontology.

[2]  Juan I. Young,et al.  Phenotypic Consequences of Copy Number Variation: Insights from Smith-Magenis and Potocki-Lupski Syndrome Mouse Models , 2010, PLoS biology.

[3]  E. Eichler,et al.  Phenotypic variability and genetic susceptibility to genomic disorders. , 2010, Human molecular genetics.

[4]  P. Scambler,et al.  Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants , 2010, Heart.

[5]  H. Nawa,et al.  Activation of mammalian target of rapamycin signaling in spatial learning , 2010, Neuroscience Research.

[6]  Juan I. Young,et al.  Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome , 2010, BMC Molecular Biology.

[7]  Jesse Gillis,et al.  Gene function analysis in complex data sets using ErmineJ , 2010, Nature Protocols.

[8]  P. Pavlidis,et al.  Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics , 2010, Human Genetics.

[9]  G. Karaca,et al.  Topoisomerase IIα maintains genomic stability through decatenation G2 checkpoint signaling , 2010, Oncogene.

[10]  Richard Redon,et al.  Confirmed rare copy number variants implicate novel genes in schizophrenia. , 2010, Biochemical Society transactions.

[11]  D. Conrad,et al.  Dosage Sensitivity Shapes the Evolution of Copy-Number Varied Regions , 2010, PloS one.

[12]  Deborah L. Levy,et al.  A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.

[13]  L. Armengol,et al.  BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1 , 2009, BMC Medical Genetics.

[14]  M. Pellegrini,et al.  Copy number variation influences gene expression and metabolic traits in mice. , 2009, Human molecular genetics.

[15]  W. Deng.  PARylation: strengthening the connection between cancer and pluripotency. , 2009, Cell stem cell.

[16]  S. West,et al.  Poly(ADP-ribose)–Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1 , 2009, Science.

[17]  M. O’Driscoll,et al.  Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency. , 2009, DNA repair.

[18]  X. Guan,et al.  Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors , 2009, PloS one.

[19]  M. Washburn,et al.  Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler , 2009, Proceedings of the National Academy of Sciences.

[20]  Joshua M. Korn,et al.  De Novo Copy Number Variants Identify New Genes and Loci in Isolated, Sporadic Tetralogy of Fallot , 2009, Nature Genetics.

[21]  G. Ronnett,et al.  AMPK in the brain: its roles in energy balance and neuroprotection , 2009, Journal of neurochemistry.

[22]  A. Reymond,et al.  Copy number variants, diseases and gene expression. , 2009, Human molecular genetics.

[23]  J. Milbrandt,et al.  AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. , 2009, Developmental cell.

[24]  H. Hakonarson,et al.  Genomic Landscape of a Three-Generation Pedigree Segregating Affective Disorder , 2009, PloS one.

[25]  P. Stankiewicz,et al.  Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities , 2008, Nature Genetics.

[26]  C. Baker,et al.  Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. , 2008, The New England journal of medicine.

[27]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[28]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[29]  P. Jeggo,et al.  Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling. , 2007, American journal of human genetics.

[30]  T. Bestor,et al.  The decatenation checkpoint , 2007, British Journal of Cancer.

[31]  J. Lieberman,et al.  Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome , 2006, Molecular and Cellular Neuroscience.

[32]  E. Mickelson,et al.  Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1 , 2006, Journal of Medical Genetics.

[33]  Charlotte N. Henrichsen,et al.  Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes. , 2006, American journal of human genetics.

[34]  M. Somerville,et al.  Chromosome 1q21.1 Contiguous Gene Deletion Is Associated With Congenital Heart Disease , 2004, Circulation research.

[35]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[36]  J. Oshima,et al.  The G2-phase decatenation checkpoint is defective in Werner syndrome cells. , 2003, Cancer research.

[37]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[38]  P. Simi,et al.  Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission. , 2002, American journal of medical genetics.

[39]  D. Cimini,et al.  Differences in malsegregation rates obtained by scoring ana-telophases or binucleate cells. , 1999, Mutagenesis.

[40]  M. Fenech,et al.  Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. , 2011, Mutagenesis.

[41]  H. van Bokhoven,et al.  Genetic and epigenetic defects in mental retardation. , 2009, The international journal of biochemistry & cell biology.

[42]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.